Current Issue

Unscaling Population Health
David B. Nash, MD, MBA
November 2018 Vol 11, No 8 - Editorial
Read More
Healthcare Costs and Absenteeism Among Caregivers of Adults with Partial-Onset Seizures: Analysis of Claims from an Employer Database
Richard A. Brook, MS, MBA, Krithika Rajagopalan, PhD, James E. Smeeding, RPh, MBA
November 2018 Vol 11, No 8 - Business, Original Research
Stakeholder Perspective
The Importance of Clinical and Economic Support Systems for Caregivers
by Michael Kleinrock
Read More
Patient Preferences Associated with Therapies for Psoriatic Arthritis: A Conjoint Analysis
Yihua Xu, PhD, Lavanya Sudharshan, MS, Ming-Ann Hsu, MPH, Andrew S. Koenig, DO, FACR, Joseph C. Cappelleri, PhD, MPH, MS, Wen F. Liu, PharmD, BCPS, Timothy W. Smith, Margaret K. Pasquale, PhD
November 2018 Vol 11, No 8 - Clinical, Original Research
Stakeholder Perspective
Engaging Patients in Decision-Making for Psoriatic Arthritis Treatment
by F. Randy Vogenberg, RPh, PhD
Read More
FDA Commissioner Outlines New Plan to Increase Biosimilars by Balancing Innovation and Competition
Eileen Koutnik-Fotopoulos
November 2018 Vol 11, No 8 - Industry Trends
Read More
Treatment Tolerability in Patients with Immunoglobulin Light-Chain Amyloidosis
Avery A. Rizio, PhD, Michelle K. White, PhD, Kristen L. McCausland, MPH, PhD, Tiffany P. Quock, MS, PhD, Spencer D. Guthrie, MS, MBA, MPH, Miyo Yokota, PhD, Martha Bayliss, MS, MSc
November 2018 Vol 11, No 8 - Clinical, Original Research
Read More

Conference Correspondent

Pooled Analysis of Safety Data from Phase 2 and 3 Clinical Trials Evaluating Eravacycline in Complicated Intra-Abdominal Infections
Conference Correspondent - IDWeek 2018
Integrated Safety Summary of Omadacycline, A Novel Aminomethylcycline Antibiotic
Conference Correspondent - IDWeek 2018
Health-Related Social Vulnerabilities in a Pediatric Outpatient Antimicrobial Therapy Program
Conference Correspondent - IDWeek 2018

Most Popular Articles

Computed Tomography Colonography Less Costly Than Colonoscopy for Colorectal Cancer Screening of Commercially Insured Patients
Tia Goss Sawhney, DrPH, FSA, MAAA, Bruce S. Pyenson, FSA, MAAA, David Rotter, PhD, Michele Berrios, Judy Yee, MD
October 2018 Vol 11, No 7 - Business, Original Research
Budget Impact Analysis of Using Daunorubicin-Cytarabine Liposome in Patients with Newly Diagnosed Therapy-Related AML or AML and Myelodysplasia-Related Changes
Ivar S. Jensen, MBA, Elizabeth Wu, MPH, Naomi C. Sacks, PhD, Philip L. Cyr, MPH, Karen C. Chung, PharmD, MS
October 2018 Vol 11, No 7 - Business, Original Research
Economic Burden of Adverse Events Associated with Immunotherapy and Targeted Therapy for Metastatic Melanoma in the Elderly
Sameer R. Ghate, PhD, Zhiyi Li, MBA, MA, Jackson Tang, MSc, Antonio Reis Nakasato, MD
October 2018 Vol 11, No 7 - Business, Original Research

Web Exclusive

A “Gold Standard” for Population Health? Revisiting the FDA’s Relationship with the Hippocratic Oath
Gillian Woollett, MA, DPhil , Bruce S. Pyenson, FSA, MAAA
Perhaps the greatest turning point in the history of medicine occurred sometime in the 20th century, when medical practice started doing more good than harm.
Read More

Select Drug Updates

Welcome to the Ninth Annual Payers’ Guide to New FDA Approvals
FDA Approvals in 2017 Represent a 21-Year High
FDA Approvals of Brand-Name Prescription Drugs in 2017
Bavencio (Avelumab) Approved for Metastatic Merkel-Cell Carcinoma and for Urothelial Carcinoma
View All Updates

Reader Poll

*Should the government fund healthcare cost-sharing payments to insurers to reduce the economic burden on consumers?


  • Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • Lynx CME